BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18418769)

  • 1. No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cells.
    Sundin M; Remberger M; Lönnies H; Sundberg B; Ringdén O; Le Blanc K
    Cytotherapy; 2008; 10(3):238-42. PubMed ID: 18418769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.
    Poloni A; Maurizi G; Rosini V; Mondini E; Mancini S; Discepoli G; Biasio S; Battaglini G; Felicetti S; Berardinelli E; Serrani F; Leoni P
    Cytotherapy; 2009; 11(2):153-62. PubMed ID: 19301169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use.
    Haack-Sorensen M; Bindslev L; Mortensen S; Friis T; Kastrup J
    Cytotherapy; 2007; 9(4):328-37. PubMed ID: 17573608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.
    Müller I; Kordowich S; Holzwarth C; Spano C; Isensee G; Staiber A; Viebahn S; Gieseke F; Langer H; Gawaz MP; Horwitz EM; Conte P; Handgretinger R; Dominici M
    Cytotherapy; 2006; 8(5):437-44. PubMed ID: 17050248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases.
    Dimitriou H; Linardakis E; Martimianaki G; Stiakaki E; Perdikogianni CH; Charbord P; Kalmanti M
    Cytotherapy; 2008; 10(2):125-33. PubMed ID: 18368591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains.
    Barzilay R; Sadan O; Melamed E; Offen D
    Cytotherapy; 2009; 11(4):435-42. PubMed ID: 19521891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.
    Pal R; Venkataramana NK; Bansal A; Balaraju S; Jan M; Chandra R; Dixit A; Rauthan A; Murgod U; Totey S
    Cytotherapy; 2009; 11(7):897-911. PubMed ID: 19903102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosis.
    Uckan D; Kilic E; Sharafi P; Kazik M; Kaya F; Erdemli E; Can A; Tezcaner A; Kocaefe C
    Cytotherapy; 2009; 11(4):392-402. PubMed ID: 19337938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients.
    Coipeau P; Rosset P; Langonne A; Gaillard J; Delorme B; Rico A; Domenech J; Charbord P; Sensebe L
    Cytotherapy; 2009; 11(5):584-94. PubMed ID: 19626496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression.
    Montesinos JJ; Flores-Figueroa E; Castillo-Medina S; Flores-Guzmán P; Hernández-Estévez E; Fajardo-Orduña G; Orozco S; Mayani H
    Cytotherapy; 2009; 11(2):163-76. PubMed ID: 19152152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation.
    Rieger K; Marinets O; Fietz T; Körper S; Sommer D; Mücke C; Reufi B; Blau WI; Thiel E; Knauf WU
    Exp Hematol; 2005 May; 33(5):605-11. PubMed ID: 15850839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells.
    Samuelsson H; Ringdén O; Lönnies H; Le Blanc K
    Cytotherapy; 2009; 11(2):129-36. PubMed ID: 19152151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow.
    Jones EA; English A; Kinsey SE; Straszynski L; Emery P; Ponchel F; McGonagle D
    Cytometry B Clin Cytom; 2006 Nov; 70(6):391-9. PubMed ID: 16977637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood.
    Manca MF; Zwart I; Beo J; Palasingham R; Jen LS; Navarrete R; Girdlestone J; Navarrete CV
    Cytotherapy; 2008; 10(1):54-68. PubMed ID: 18202975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
    Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation.
    Pozzi S; Lisini D; Podestà M; Bernardo ME; Sessarego N; Piaggio G; Cometa A; Giorgiani G; Mina T; Buldini B; Maccario R; Frassoni F; Locatelli F
    Exp Hematol; 2006 Jul; 34(7):934-42. PubMed ID: 16797421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could cord blood be a source of mesenchymal stromal cells for clinical use?
    Perdikogianni C; Dimitriou H; Stiakaki E; Martimianaki G; Kalmanti M
    Cytotherapy; 2008; 10(5):452-9. PubMed ID: 18821358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice.
    Feng SW; Lu XL; Liu ZS; Zhang YN; Liu TY; Li JL; Yu MJ; Zeng Y; Zhang C
    Cytotherapy; 2008; 10(3):254-64. PubMed ID: 18418771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
    Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
    Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.